Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01317823
Other study ID # BS_CL_02
Secondary ID
Status Completed
Phase N/A
First received March 16, 2011
Last updated October 21, 2012
Start date December 2008
Est. completion date April 2012

Study information

Verified date October 2012
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review BoardKorea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

To compare the ultrasonographic cervical length with the Bishop score in determining the administration of prostaglandin for preinduction cervical ripening in multiparous women at term.


Recruitment information / eligibility

Status Completed
Enrollment 154
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- multiparous patients

- singleton pregnancy

- live fetus with vertex presentation

- intact amniotic membranes

- > 37 weeks gestation

- absence of labor

- no previous uterine surgical procedures

Exclusion Criteria:

- major congenital anomaly

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Assessment of cervical status
Assessment of cervical status based on Bishop score versus sonographically measured cervical length

Locations

Country Name City State
Korea, Republic of Department of Obstetrics and Gynecology Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Successful labor induction Induction success was defined as an ability to achieve the active phase of labor corresponding to a cervical dilatation of = 4 cm within 11 hours of initiating oxytocin (i.e., within 22 hours of the administration of a dinoprostone vaginal insert) on the first day of induction. Eleven hours of initiating oxytocin on the fist day of induction No
Secondary the need for oxytocin induction, percentage of patients treated with prostagladins the interval from start of oxytocin to the active phase of labor
the interval from start of oxytocin to delivery
vaginal delivery within 24 hours of starting induction
the incidence of cesarean delivery
After removing prostaglandin, the following day when an intravenous oxytocin infusion was started No
See also
  Status Clinical Trial Phase
Completed NCT02618096 - Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Multiparous Women at Term N/A
Completed NCT01317706 - Comparison Between Ultrasonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment N/A
Completed NCT01596296 - Foley Catheter Versus Dinoprostone Vaginal Insert for Induction of Labor in Parous Women at Term: A Randomized Trial N/A
Completed NCT02485821 - Vaginal Estradiol Pretreatment in Labour Induction With Misoprostol Phase 2/Phase 3
Completed NCT02314260 - Modifying Cervical Bishop Scoring System N/A
Completed NCT01317862 - A Comparison of Transcervical Foley Catheter and Prostaglandins for Induction of Labor at Term N/A
Completed NCT01506388 - A Novel Protocol for Labour Induction Phase 3
Completed NCT02524002 - Enhanced vs. Routine Clear Liquid Intake in Labor N/A
Completed NCT02416583 - Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term N/A